- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07296861
HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome (HomeGrown)
The goal of this project is to evaluate an adapted health promotion program, HomeGrown, designed to improve the health of young children with Down syndrome by supporting families in making healthy home environmental changes. There is a significant need for evidence-based programs that address healthy eating and physical activity within this population, as most existing interventions have been developed for typically developing children. By tailoring the program to the unique needs of families of young children with Down syndrome, this project aims to advance inclusion and equity in health behavior promotion.
This R61/R33 study will assess the feasibility (R61 Phase) and subsequent efficacy (R33 Phase) of the HomeGrown program in improving family practices related to nutrition and physical activity. During the R61 feasibility phase, 38 primary caregivers of children aged 2-6 years with Down syndrome will be enrolled in a 6-month randomized controlled trial. Families will be randomized 1:1 to either the HomeGrown intervention or a waitlist control group (6-month delayed start), stratified by the child's biological sex (male/female) and age (2-3 vs. 4-6 years). All measures will be collected at baseline and at 6-month follow-up.
The R61 feasibility phase will address three specific aims:
Accrual: Achieve an enrollment rate of 10 families per month, supporting feasibility for the R33 efficacy phase.
Engagement: Demonstrate that families use at least 70% of available HomeGrown intervention components, measured using the digital behavior change interventions engagement scale.
Data Collection & Retention: Achieve at least 80% retention with completion of all outcome assessments.
By addressing key gaps in nutrition and physical activity research for young children with Down syndrome, this study has the potential to improve health outcomes for an underserved population and inform future clinical and community health promotion efforts.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Emily C Clarke
- Phone Number: 919-966-6080
- Email: emily.clarke@unc.edu
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599-7426
- Recruiting
- UNC Center for Health Promotion and Disease Prevention
-
Principal Investigator:
- Erik Willis, PhD
-
Contact:
- Emily C Clarke
- Phone Number: 336-971-7459
- Email: emily.clarke@unc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Adult:
- Ability to provide informed consent
- 18 years or older
- Primary caregiver of a child with Down syndrome aged 2 to 6 years old
- Have access to WI-FI or smartphone
- Be able to read and speak English
Children:
- Be 2-6 years old.
- Are diagnosed with Down syndrome
- Are not reliant on tube feeding
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm 1- HomeGrown program
Participants will receive interventions.
|
The implementation model for supporting home environment changes focuses on engaging families in Homegrown, giving them access to interactive online tools and resources that guide behavior change, and providing monthly support check-in calls as they work to adopt evidence-based healthy eating and physical activity practices at home. Families will participate in the 6-month program with support from a trained health educator. The HomeGrown program begins with a family orientation session, followed by access to the HomeGrown web application. Participants will have access to HomeGrown intervention which is a 6-month program that helps families improve healthy eating and physical activity at home. Families start with an orientation session, then use the HomeGrown web application with interactive tools and resources. Monthly check-in calls with a trained health educator provide guidance and support throughout the program. |
|
Active Comparator: Arm 2 Waitlist control
Participants will receive interventions after study completion, 6-month delayed start.
|
Participants will have a 1-hour training with the interventionist to learn how to use a website (not HomeGrown).
Access to HomeGrown will be provided after the 6-month study is completed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accrual Rate
Time Frame: Baseline
|
Percent of eligible participants who agreed to join study.
|
Baseline
|
|
Participant Engagement
Time Frame: 6 months
|
Digital behavior change engagement scale will be measured as number of participants completed digital intervention.
|
6 months
|
|
Participant Retention
Time Frame: 6 months
|
Percent of participants who completed 6-month measures.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Physical Activity
Time Frame: 6 months
|
GT3X+ accelerometers (ActiGraph, Pensacola, FL) are small wearable devices that measure movement and physical activity levels.
worn on children's waist for 7 consecutive days.
Reminders about wearing and returning the device will be sent via email/text throughout each assessment period.
Video instructions will also be available through the web application.
Accelerometer data will be used to calculate the number of minutes participants spend in each physical activity level (sedentary, light, moderate, vigorous, and total non-sedentary).
|
6 months
|
|
Child Diet Quality
Time Frame: 6 months
|
Caregivers will complete 24-hour dietary recalls to report their child's food and beverage intake using the Automated Self-Administered 24-hour (ASA24) Dietary Assessment Tool. Caregivers will receive a standardized email with login details, instructions, and a prompt to complete the recall, followed by a reminder text on their assigned recall days. If a recall is still not completed, data collectors will make a final attempt to complete it with the caregiver by phone. Using the ASA24 output, Healthy Eating Index-Toddlers-2020 (HEI-2020) scores will be calculated. The HEI-2020 reflects how closely a child's diet aligns with dietary guidelines, with scores ranging from 0 to 100; higher scores indicate better diet quality. |
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Eric Willis, PhD, UNC Lineberger Comprehensive Cancer Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Nutrition Disorders
- Genetic Diseases, Inborn
- Overnutrition
- Body Weight
- Neurobehavioral Manifestations
- Congenital Abnormalities
- Abnormalities, Multiple
- Overweight
- Intellectual Disability
- Obesity
- Chromosome Disorders
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Pediatric Obesity
- Down Syndrome
- Organization and Administration
- Health Services Administration
- Appointments and Schedules
- Waiting Lists
Other Study ID Numbers
- 25-2418
- R01DK128174 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Izgi Miray DemirbagRecruitingDown Syndrome (DS)Turkey (Türkiye)
-
Brigham and Women's HospitalNational Institutes of Health (NIH)Not yet recruitingDown Syndrome (DS)United States
-
University of Nevada, Las VegasRecruiting
-
Universidad de BurgosEuropean University Miguel de CervantesRecruiting
-
Aelis FarmaHospital del Mar Research Institute (IMIM)Enrolling by invitation
-
Sohag UniversityActive, not recruitingDown Syndrome | Cervical Spine Instability in Down SyndromeEgypt
-
Alnylam PharmaceuticalsNot yet recruitingDown Syndrome-Associated Alzheimer's Disease (DS-AD)United States
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
Clinical Trials on The HomeGrown
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHeart Failure | Obesity | Type2diabetesUnited States
-
International Institute of Rescue Research and...Unknown
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Cairo UniversityCompletedClass III MalocclusionEgypt
-
Kutahya Health Sciences UniversityCompletedPain | Angiopathy, PeripheralTurkey (Türkiye)
-
Clinique BizetCompletedElectromagnetic Emissions and Emotional Disorder | Electromagnetic Emissions and Medication SavingsFrance
-
Yonsei UniversityCompletedSurgical Complications From General AnesthesiaKorea, Republic of
-
Second Affiliated Hospital, School of Medicine,...Unknown
-
Assistance Publique Hopitaux De MarseilleUnknown
-
University of ZurichTerminatedLung Disease | Wrist FractureSwitzerland